We are live on
!
Find out more
MRSN
Mersana Therapeutics
MRSN
MRSN
Delisted
MRSN was delisted on the 5th of January, 2026.
77 hedge funds and large institutions have $162M invested in Mersana Therapeutics in 2019 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 33 increasing their positions, 13 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
233% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 6
154% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 13
18% more funds holding
Funds holding: 65 → 77 (+12)
0.25% more ownership
Funds ownership: 3.1% → 3.35% (+0.25%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
17% less capital invested
Capital invested by funds: $194M → $162M (-$32.4M)
Holders
77
Holders Change
+12
Holders Change %
+18.46%
% of All Funds
1.67%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
20
Increased
33
Reduced
13
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BC
Boxer Capital
San Diego,
California
|
+$9.82M |
| 2 |
BlackRock
New York
|
+$7.03M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.9M |
| 4 |
State Street
Boston,
Massachusetts
|
+$1.63M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$786K |
